Tennessee Attorney General Jonathan Skrmetti this week led a 38-state and territory bipartisan coalition requesting that the Food and Drug Administration (FDA) take swift action against bad actors who are endangering consumers with counterfeit and unsafe forms of the weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro, and Zepbound (GLP-1 drugs).
Sky-high demand for GLP-1 medications, a high price tag, and tight supplies have created opportunities for bad actors to take advantage of consumers by manufacturing and selling counterfeit, untested products that may risk consumers’ safety.
